Kala - KALA

Option chain shows key data for Kala Bio's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Kala Bio.

Kala Bio (NASDAQ:KALA) Stock, Option Chain

KALA BIO INC

Kala Bio

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

News

Penny Stocks

Small Cap

Trading Ideas

$BTC

AGLE

AIRS

APLM

BFRG

GFAI

GREE

KALA

RAIN

TORO

VCIG

BRFG

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move.

High short interest and steep borrowing costs are among the common traits that could lead to a short squeeze.

10 Short Squeeze Stocks To Watch: Aeglea Biotherapeutics, Toro Corp, AirSculpt, A Company Moves Up 4,166 Positions &amp; More

ELEV

GETY

INAB

LUNR

MLTX

MULN

PXMD

Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move.

High-short interest and high-cost to borrow are among the common traits that could lead to a short squeeze.

10 Short Squeeze Stocks To Watch: Toro Corp, PaxMedica, Getty Images And More

Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the next huge move.

High short interest and high cost to borrow are among the common traits that could lead to a short squeeze.

5 Short Squeeze Stocks To Watch: Getty Images, Bullfrog AI And A New Leader For The Week

Kala Bio Inc

KALAMAZOO RESOURCES by KALAMAZOO RESOURCES LTD.

Kalamazoo Resources Ltd

Kalao

Kalaris Therapeutics, Inc. - Common Stock

Kalaris Therapeutics Inc

Press Releases

KALA BIO to Present at Jefferies Global Healthcare Conference

Financing

KALA BIO Announces $12,500,000 Private Placement

Earnings

KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update

KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update

KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference

KALA BIO Announces $10,750,000 Private Placement

Management

KALA BIO Announces Chief Executive Officer Transition

Health Care

KALA BIO to Present at TD Cowen 45th Annual Health Care Conference

KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

ABVC BioPharma

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

BioVie

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

Cardio Diagnostics Holdings Inc. - Common stock

Cardio Diagnostics Hldgs

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies

Clene

Chemomab Therapeutics Ltd. - American Depositary Shares

Chemomab Therapeutics

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics

Curis

CEL-SCI

Elevation Oncology

GlycoMimetics

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Longeveron

LakeShore Biopharma Co., Ltd - Ordinary Shares

LakeShore Biopharma

Lisata Therapeutics

Nanoviricides

Ovid Therapeutics

Passage Bio

Q32 Bio

Tenax Therapeutics

Tempest Therapeutics, Inc. - Common Stock

Tempest Therapeutics

Unity Biotechnology

X4 Pharmaceuticals

HC Wainwright & Co.

Oppenheimer

Kala Pharmaceuticals

Comments

Kala Bio

Kala Bio (KALA) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell